Breast cancer can be subclassified into five intrinsic subtypes, that is, luminal A, luminal B, HER2‐enriched, basal, and normal‐like, which reflect fundamental differences at the molecular level and thus distinct clinical outcomes, mainly in patients with early breast cancer [21, 22, 23, 24]. Here, ERBB2 is linked to breast carcinoma.